Valuation: Highnoon Laboratories Limited

Market Cap 55.88B 201M 176M 162M 151M 285M 19.16B 290M 1.91B 754M 9.41B 755M 739M 32.49B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 55.88B 201M 176M 162M 151M 285M 19.16B 290M 1.91B 754M 9.41B 755M 739M 32.49B EV / Sales 2026 *
1.84x
EV / Sales 2027 * 1.64x
Free-Float
50.02%
Yield 2026 *
4.27%
Yield 2027 * 4.93%
1 day+1.92%
1 week+5.69%
Current month+5.18%
1 month+8.03%
3 months+23.94%
6 months-1.40%
Current year+3.15%
1 week 987.95
Extreme 987.95
1,075
1 month 960
Extreme 960
1,075
Current year 755.56
Extreme 755.56
1,101
1 year 755.56
Extreme 755.56
1,241
3 years 330
Extreme 330
1,241
5 years 322.1
Extreme 322.1
1,241
10 years 127.86
Extreme 127.8558
1,241
Manager TitleAgeSince
Chief Executive Officer - 2015-03-31
Chief Executive Officer 63 1995-12-31
Director of Finance/CFO - 2020-03-31
Director TitleAgeSince
Chairman - 2025-06-30
Chairman - 2012-09-06
Chairman - -
Change 5-day change 1-year change 3-year change Capi.($)
+1.92%+5.69%+6.20%+199.58% 201M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
-0.26%+1.37%+31.00%+23.97% 338B
-0.56%+0.96%+39.86%+36.64% 299B
-0.08%+1.30%+30.37%+44.02% 291B
-1.54%+2.81%-27.56%-39.45% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +1.67%+4.65%+28.48%+71.96% 369.26B
Weighted average by Cap. +1.87%+5.43%+41.75%+82.98%

Financials

2026 *2027 *
Net sales 30.4B 109M 95.63M 87.91M 81.89M 155M 10.42B 158M 1.04B 410M 5.12B 411M 402M 17.67B 34.16B 123M 107M 98.8M 92.04M 175M 11.72B 178M 1.17B 461M 5.75B 461M 452M 19.86B
Net income - -
Net Debt - -
Logo Highnoon Laboratories Limited
Highnoon Laboratories Limited is a Pakistan-based company that is engaged in the manufacturing, importing, selling, and marketing of pharmaceutical and related consumer products. Its product categories include cardiology, metabolic, gastroenterology, musculoskeletal, anti-infective, obstetrics and gynecology, pediatrics, allergy, respiratory, and urology. Its cardiology products include Cuziper, Hitica, Apiban, Misar, and Herbesser. Its metabolic products include Daploz, Tagip, Diajard, and Nylomet. Its gastroenterology products include Rabecid, Racedo, Skilax, and Fosbu. Its musculoskeletal products include Kydor, Hilin, Airtal, and Tamadol. Its anti-infective products include Evacef, Maxum, Efix, and Cefia. Its obstetrics and gynecology products include Hitase. Its pediatrics product includes Tres Orix Forte. Its allergy products include Leviva and Kestine. Its respiratory products include Combivair Forte, Glynvair, Betatec, Ultivair, and Montit. Its urology products include Prostam.
Employees
2,563
Date Price Change Volume
26-07-03 PKR 1,054.67 +1.92% 93,895
26-07-02 PKR 1,034.80 +2.71% 56,020
26-07-01 PKR 1,007.54 +0.48% 141,439
26-06-30 PKR 1,002.70 +1.18% 30,818
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1,054.67PKR
Average target price
1,121.00PKR
Spread / Average Target
+6.29%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. HINOON Stock